Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1403, Issue 1, 1998, Pages 47-56

  Pruzanski, Waldemar ^a   Stefanski, Eva ^a   Vadas, Peter ^a   Kennedy, Brian P ^b   Van Den Bosch, Henk ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cytokine; Growth factor; Osteoblast; Phospholipase A2

Indexed keywords

CYCLOOXYGENASE 2; GROWTH FACTOR; PHOSPHOLIPASE A2;

ANIMAL CELL; ARTICLE; ENZYME REGULATION; ENZYME RELEASE; FETUS; GENE EXPRESSION REGULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELLS, CULTURED; CYCLOHEXIMIDE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYTOSOL; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; INTERLEUKIN-1; ISOENZYMES; NITROBENZENES; OSTEOBLASTS; PHOSPHOLIPASES A; PLATELET-DERIVED GROWTH FACTOR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; RNA, MESSENGER; SULFONAMIDES; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0032572073     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(98)00029-9     Document Type: Article

References (72)

1. [1] S.W. Evans, J.T. Whicher, Immunol. Med. Series, in: J.T. Whicher, S.W. Evans (Eds.), Vol. 18, Kluwer. Acad. Publ., London, 1992, pp. 1-15.
2. [2] S. Akira, T. Hirano, T. Taga, T. Kishimoto, FASEB J. 4 (1990) 2860-2867.
3. [3] W.P. Arend, J.-M. Dayer, Arthritis Rheum. 33 (1990) 305-315.
4. [4] C. Schalkwijk, J. Pfeilschifter, F. Marki, H. van den Bosch, Biochem. Biophys. Res. Commun. 174 (1991) 268-275.
5. [5] M. Goppelt-Struebe, W. Rehfeldt, Biochim. Biophys. Acta 1127 (1992) 163-167.
6. [6] P. Vadas, W. Pruzanski, E. Stefanski, L.G. Ellies, J.E. Aubin, A. Sos, A. Melcher, Immunol. Lett. 28 (1991) 187-194.
7. [7] P. Vadas, J. Browning, J. Edelson, W. Pruzanski, J. Lipid Mediators 8 (1993) 1-30.
8. [8] J. Angel, F. Berenbaum, C. Le Denmat, T. Nevalainen, J. Masliah, C. Fournier, Eur. J. Biochem. 226 (1994) 125-131.
9. [9] C.G. Schalkwijk, E. de Vet, J. Pfeilschifter, H. van den Bosch, Eur. J. Biochem. 210 (1992) 169-176.
10. [10] C.G. Schalkwijk, M. Vervoordeldonk, J. Pfeilschifter, H. van den Bosch, FEBS Lett. 333 (1993) 339-343.
11. [11] K.I. Hulkower, W.C. Hope, T. Chen, C.M. Anderson, J.W. Coffey, D.W. Morgan, Biochem. Biophys. Res. Commun. 184 (1992) 712-718.
12. [12] W. Pruzanski, P. Vadas, V. Fornasier, J. Invest. Dermatol. 86 (1986) 380-383.
13. [13] P. Vadas, W. Pruzanski, J. Kim, V. Fornasier, Am. J. Pathol. 134 (1989) 807-811.
14. [14] J.S. Bomalaski, P. Lawton, J. Browning, J. Immunol. 146 (1991) 3904-3910.
15. [15] G. Cirino, C. Cicala, L. Sorrentino, F.M. Maiello, J.L. Browning, J. Rheumatol. 21 (1994) 824-829.
16. [16] M. Koo Seen Lin, V. Farewell, P. Vadas, A.A.M. Bookman, E.C. Keystone, W. Pruzanski, J. Rheumatol. 23 (1996) 1162-1166.
17. [17] W. Pruzanski, K. Albin-Cook, R. Laxer, J. MacMillan, E. Stefanski, P. Vadas, E. Silverman, J. Rheumatol. 21 (1994) 1951-1954.
18. [18] P. Vadas, W. Pruzanski, E. Stefanski, B. Sternby, R. Mustard, J. Bohnen, I. Fraser, V. Farewell, C. Bombardier, Crit. Care Med. 16 (1988) 1-7.
19. [19] P. Vadas, K. Scott, G. Smith, I. Rajkovic, E. Stefanski, B.D. Scheuten, R. Singh, W. Pruzanski, Life Sci. 50 (1992) 807-811.
20. [20] P. Vadas, B. Schouten, E. Stefanski, K. Scott, W. Pruzanski, Crit. Care Med. 21 (1993) 1087-1091.
21. [21] P. Vadas, J. Keystone, E. Stefanski, K. Scott, W. Pruzanski, Infect. Immun. 60 (1992) 3928-3931.
22. [22] L.G. Ellies, J.N.M. Heersche, P. Vadas, W. Pruzanski, E. Stefanski, J.E. Aubin, J. Bone Miner. Res. 6 (1991) 843-850.
23. [23] W. Pruzanski, E. Bogoch, E. Stefanski, M. Wloch, P. Vadas, J. Rheumatol. 17 (1990) 1386-1391.
24. [24] S. Oka, H. Arita, J. Biol. Chem. 266 (1991) 9956-9960.
25. [25] T. Nakano, O. Ohara, H. Teraoka, H. Arita, FEBS Lett. 261 (1990) 171-174.
26. [26] R.M. Crowl, T.J. Stoller, R.R. Conroy, C.R. Stoner, J. Biol. Chem. 266 (1991) 2647-2651.
27. [27] S.C. Gilman, J. Chang, P.R. Zeigler, J. Uhl, E. Mochan, Arthritis Rheum. 31 (1988) 126-130.
28. [28] R.F. Flower, Br. J. Pharmacol. 94 (1988) 987-1015.
29. [29] Y. Suwa, I. Kudo, A. Imaizumi, M. Okada, T. Kimimura, Y. Suzuki, H.W. Chang, S. Hara, K. Inoue, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 2395-2399.
30. [30] H.G. Beaton, C. Bennion, S. Connolly, A.R. Cook, N.P. Gensmantel, C. Hallam, K. Hardy, B. Hitchin, C.G. Jackson, D.H. Robinson, J. Med. Chem. 37 (1994) 557-559.
31. [31] R.A. LeMahieu, M. Carson, R.J. Han, V.S. Madison, W.C. Hope, T. Chen, D.W. Morgan, H.S. Hendrickson, J. Med. Chem. 36 (1993) 3029-3031.
32. [32] A. Miyake, H. Yamamoto, E. Kubota, K. Hamaguchi, A. Kouda, K. Honda, H. Kawashima, Br. J. Pharmacol. 110 (1993) 447-453.
33. [33] K. Tanaka, S. Matsutani, K. Matsumoto, T. Yoshida, J. Antibiotics 45 (1993) 1071-1078.
34. [34] M. Feldmann, F.M. Brennan, R.O. Williams, A.P. Cope, D.L. Gibbons, P.D. Katsikis, R.N. Maini, Prog. Growth Factor Res. 4 (1992) 247-255.
35. [35] E. Stefanski, W. Pruzanski, B. Sternby, P. Vadas, J. Biochem. 100 (1986) 1297-1303.
36. [36] J.G. de Jong, H. Amesz, A.J. Aarsman, H.B. Lenting, H. van den Bosch, Eur. J. Biochem. 164 (1987) 129-135.
37. [37] E.A. Dennis, Trends Biol. Sci. 22 (1997) 1-2.
38. [38] H. van de Bosch, A.J. Aarsman, R.H. van Schaik, C.G. Schalkwijk, F.W. Neijs, A. Sturk, Biochem. Soc. Trans. 18 (1990) 781-785.
39. [39] J. Pfeilschifter, C. Schalkwijk, V.A. Briner, H. van den Bosch, J. Clin. Invest. 92 (1993) 2516-2523.
40. [40] J. Pfeilschifter, W. Pignat, K. Vosbeck, F. Marki, Biochem. Biophys. Res. Commun. 159 (1989) 385-394.
41. [41] C. Schalkwijk, J. Pfeilschifter, F. Marki, Biochem. Biophys. Res. Commun. 174 (1991) 268-275.
42. [42] K.I. Hulkower, S.J. Wertheimer, W. Levin, J.W. Coffey, C.M. Anderson, T. Chen, D.L. DeWitt, R.M. Crowl, W.C. Hope, D.W. Morgan, Arthritis Rheum. 37 (1994) 653-661.
43. [43] F. Berenbaum, G. Thomas, S. Poiraudeau, G. Bereziat, M.T. Corvol, J. Masliah, FEBS Lett. 340 (1994) 51-55.
44. [44] B. Lyons-Giordano, M.A. Pratta, W. Galbraith, G.L. Davis, E.C. Arner, Exp. Cell Res. 206 (1993) 58-62.
45. [45] W. Pruzanski, E. Bogoch, A. Katz, M. Wloch, E. Stefanski, B. Grouix, G. Sakotic, P. Vadas, J. Rheum. 22 (1995) 2114-2119.
46. [46] S. Alsalameh, B. Mattka, H.M. Lorenz, B. Manger, K. Pfizenmaier, M. Gorell, J.R. Kalden, Athritis Rheum. 39 (1996) S36, Supplement.
47. [47] H. van den Bosch, C. Schalkwijk, J. Pfeilschifter, F. Marki, Adv. Exp. Med. Biol. 318 (1992) 1-10.
48. [48] C. Schalkwijk, M. Vervoordeldonk, J. Pfeilschifter, F. Marki, H. van den Bosch, Biochem. Biophys. Res. Commun. 180 (1991) 46-52.
49. [49] H. van den Bosch, in: Esterases, lipases and phospholipases: from structure to clinical significance, NATO Advanced Research Workshop, 1993, p. 26.
50. [50] C. Schalkwijk, J. Pfeilschifter, F. Marki, H. van den Bosch, J. Biol. Chem. 267 (1992) 8846-8851.
51. [51] M.J. Vervoordeldonk, C.G. Schalkwijk, B.S. Vishwanath, A.J. Aarsman, H. van den Bosch, Biochim. Biophys. Acta 1224 (1994) 541-550.
52. [52] H. Muhl, T. Geiger, W. Pignat, F. Marki, H. van den Bosch, K. Vosbeck, J. Pfeilschifter, FEBS Lett. 291 (1991) 249-252.
53. [53] J. Pfeilschifter, W. Pignat, J. Leighton, F. Marki, K. Vosbeck, S. Alkan, Biochem. J. 270 (1990) 269-271.
54. [54] H.J. Goldberg, M.M. Viegas, B.L. Margolis, J. Schlessinger, K.L. Skorecki, Biochem. J. 267 (1990) 461-465.
55. [55] M. Bolognese, M. McCord, L.A. Marshall, Biochim. Biophys. Acta 1256 (1995) 201-209.
56. [56] J. Domin, E. Rozengurt, J. Biol. Chem. 268 (1993) 8927-8934.
57. [57] N. Hack, B. Margolis, A. Ullrich, J. Schlessinger, K. Skorecki, JASN 1 (1990) 455.
58. [58] J.V. Bonventre, J.H. Gronich, R.A. Nemenoff, J. Biol. Chem. 265 (1990) 4934-4938.
59. [59] R.M. Johnson, M.A. Napier, M.J. Cronin, K.L. King, Endocrinology 127 (1990) 2099-2103.
60. [60] A.J.R. Habenicht, J.A. Glomset, W.C. King, C. Nist, C.D. Mitchell, R. Ross, J. Biol. Chem. 256 (1981) 12329-12335.
61. [61] L.J. Pike, D.F. Bowen-Pope, R. Ross, E.G. Krebs, J. Biol. Chem. 258 (1983) 9383-9390.
62. [62] S.J. Decker, J. Biochem. 268 (1993) 9176-9179.
63. [63] T. Taga, T. Kishimoto, FASEB J. 7 (1993) 3387-3396.
64. [64] T. Kadowaki, S. Koyasu, E. Nishida, K. Tobe, T. Izumi, F. Takaku, H. Sakai, I. Yahara, M. Kasuga, J. Biochem. 262 (1987) 7342-7350.
65. [65] F.C. Nielsen, Growth Factor Res. 4 (1992) 257-290.
66. [66] W.S. Chen, C.S. Lazar, M. Poenie, R.Y. Tsien, G.N. Gill, M.G. Rosenfeld, Nature 328 (1987) 820-823.
67. [67] H.Y. Lin, X.-F. Wang, E. Ng-Eaton, R.A. Weinberg, H.F. Lodish, Cell 68 (1992) 775-785.
68. [68] C.G. Schalkwijk, M. Spaargaren, L.H.K. Defize, A.J. Verkleij, H. van den Bosch, J. Boonstra, Eur. J. Biochem. 231 (1995) 593-601.
69. 2. Basic and clinical aspects in inflammatory diseases, Prog. Surg. 24 (1997) 23-30.
70. [70] F. Berenbaum, C. Jacques, G. Thomas, M.T. Corvol, G. Bereziat, J. Masliah, Exp. Cell. Res. 222 (1996) 379-384.
71. [71] H. Kawaguschi, C.C. Pilbeam, G. Gronowicz, C. Abreu, B.S. Fletcher, H.R. Herschman, L.G. Raisz, M.M. Hurley, J. Clin. Invest. 96 (1995) 923-930.
72. [72] D.H. Goddard, S.L. Grossman, R. Newton, M.A. Clark, J.S. Bomalaski, Cytokine 4 (1992) 377-384.